Fig. 7. Neuroprotection of pyruvate and succinate against apoptosis. Serum
withdrawal from the culture medium resulted in 50-60% cell death in 30 hours,
measured by LDH release and Trypan Blue extrusion. (A) Bright phase photos of
Trypan-Blue-treated pure-neuronal cultures before and after serum deprivation.
Normal cells do not show positive staining with Trypan Blue (dark color);
after a 30-hour incubation in the serum-free medium many Trypan-Blue-positive
cells represent the injured or dead cells lack of ability to extrude the dye
from the intracellular space. Addition of 5 mM pyruvate in the serum-free
medium attenuated Trypan Blue staining and cell death. Bar, 50 µm. (B)
Pyruvate attenuated serum deprivation-induced cell death in a
concentration-dependent manner; the neuroprotection was mostly reversed by
co-applied 4-CIN (2 mM). Neuroprotective effects were achieved even when
pyruvate was given up to 4 hours after the onset of serum deprivation. (C)
Succinate at 5 mM showed little neuroprotective effect, increasing its
concentration to 20 mM reduced serum deprivation-induced apoptosis, consistent
with its effect on Ipump and ROS production at this
concentration. The succinate downstream metabolite oxaloacetate (5 mM) also
showed comparable neuroprotection against serum deprivation-induced apoptosis.
(D) Co-applied pyruvate (5 mM) showed no attenuating effect on the neuronal
death induced by C2-ceramide (25 µM, 48-hour exposure). In fact,
pyruvate appeared to increase the C2-ceramide toxicity, which is
consistent with a lower pump current in the presence of pyruvate and
C2-ceramide (see Fig.
2C). n=8-31 cultures. *P<0.05 compared with
serum deprivation alone; #P<0.05 compared with serum deprivation
plus pyruvate.